BCRX · Biocryst Pharmaceuticals Inc · Proposed Sales
$7.61
-0.07 (-0.91%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.96B
Shares
257.30M
Volume · Nov 13
2.32M
Avg daily vol (3M)
4.87M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-05-13 | Barnes Alane P | Officer | 62,500 | 2026-05-13 | Fidelity Brokerage Services LLC |
| 2026-03-20 | HEGGIE THERESA | Director | 49,933 | 2026-03-20 | Fidelity Brokerage Services LLC |
| 2026-03-16 | Barnes Alane P | Officer | 150,000 | 2026-03-16 | Fidelity Brokerage Services LLC |
| 2026-03-02 | Stonehouse Jon P | Director | 305,995 | 2026-03-02 | Fidelity Brokerage Services LLC |
| 2025-12-22 | Barnes Alane P | Officer | 21,773 | 2025-12-22 | Fidelity Brokerage Services LLC |
| 2025-12-15 | Barnes Alane P | Officer | 21,210 | 2025-12-15 | Fidelity Brokerage Services LLC |
| 2025-12-03 | Barnes Alane P | Officer | 19,770 | 2025-12-03 | Fidelity Brokerage Services LLC |
| 2025-12-02 | Barnes Alane P | Officer | 50,906 | 2025-12-02 | Fidelity Brokerage Services LLC |
| 2025-12-01 | Barnes Alane P | Officer | 91,004 | 2025-12-01 | Fidelity Brokerage Services LLC |
| 2025-11-25 | Helen M Thackray | Officer | 48,229 | 2025-11-25 | Merrill Lynch |
| 2025-11-21 | Helen Thackray | Officer | 43,275 | 2025-11-21 | Merrill Lynch |
| 2025-11-13 | SANDERS MACHELLE | Officer | 9,600 | 2025-11-13 | Fidelity Brokerage Services LLC |
| 2025-08-13 | HEGGIE THERESA | Director | 70,000 | 2025-08-13 | Fidelity Brokerage Services LLC |
| 2024-12-13 | Hutson Nancy J | Director | 7,000 | 2024-12-13 | Merrill Lynch |
| 2024-06-24 | McKee Amy E | Director | 8,600 | 2024-06-24 | Merrill Lynch |
| 2024-06-17 | SANDERS MACHELLE | Director | 4,689 | 2024-06-17 | Merrill Lynch |
| 2024-06-14 | HEGGIE THERESA | Director | 6,698 | 2024-06-14 | Merrill Lynch |
| 2023-06-15 | SANDERS MACHELLE | Officer | 4,000 | 2023-06-15 | Merrill Lynch |
| 2023-06-14 | Hutson Nancy J | Officer | 12,866 | 2023-06-14 | Merrill Lynch |
Showing 1–19 of 19 filings
Key facts
CIK
882796
CUSIP
09058V103
13F (30d)
246 filings
226 filers
Visit website
Investor relations